 <h1>Gocovri Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>amantadine</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li>
<li>FAQ</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about amantadine. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Gocovri.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to amantadine: oral capsule, oral capsule extended release, oral capsule liquid filled, oral syrup, oral tablet, oral tablet extended release</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, amantadine (the active ingredient contained in Gocovri) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking amantadine:</p><p>
<i>More common</i>
</p><ul>
<li>Bladder pain</li>
<li>bloody or cloudy urine</li>
<li>blurred vision</li>
<li>confusion</li>
<li>difficult, burning, or painful urination</li>
<li>dizziness or lightheadedness</li>
<li>fainting</li>
<li>falls</li>
<li>frequent urge to urinate</li>
<li>lower back or side pain</li>
<li>seeing, hearing, or feeling things that are not there</li>
<li>swelling of the hands, feet, or lower legs</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Inability to move the eyes</li>
<li>increased blinking or spasms of the eyelid</li>
<li>muscle spasm</li>
<li>sticking out of the tongue</li>
<li>troubled breathing, speaking, or swallowing</li>
<li>uncontrolled twisting movements of the neck, trunk, arms, or legs</li>
<li>unusual facial expressions</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Chills</li>
<li>decreased vision or any change in vision</li>
<li>difficulty in coordination</li>
<li>fever</li>
<li>increased blood pressure</li>
<li>increase in body movements</li>
<li>irritation and swelling of the eye</li>
<li>loss of memory</li>
<li>mental depression</li>
<li>seizures</li>
<li>severe mood or mental changes</li>
<li>skin rash</li>
<li>slurred speech</li>
<li>sore throat</li>
<li>thoughts of suicide or attempts at suicide</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of amantadine may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Agitation</li>
<li>anxiety</li>
<li>difficulty concentrating</li>
<li>headache</li>
<li>irritability</li>
<li>loss of appetite</li>
<li>nausea</li>
<li>nervousness</li>
<li>nightmares</li>
<li>purplish red, net-like, or blotchy spots on the skin</li>
<li>trouble with sleeping</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Constipation</li>
<li>decrease in sexual desire</li>
<li>diarrhea</li>
<li>drowsiness</li>
<li>dryness of the mouth, nose, and throat</li>
<li>false sense of well-being</li>
<li>unusual tiredness or weakness</li>
<li>vomiting</li>
</ul><p>
<!-- end oral capsule, oral capsule extended release, oral capsule liquid filled, oral syrup, oral tablet, oral tablet extended release --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to amantadine: compounding powder, oral capsule, oral capsule extended release, oral syrup, oral tablet, oral tablet extended release</i></p><h3>General</h3><p>The more commonly reported adverse reactions have included nausea, dizziness/lightheadedness, and insomnia.<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Dizziness/lightheadedness, ataxia, headache, somnolence, dystonia</p>
<p><b>Uncommon</b> (0.1% to 1%): Weakness, slurred speech, hyperkinesia </p>
<p><b>Rare</b> (less than 0.1%): Convulsion</p>
<p><b>Frequency not reported</b>: Falling asleep during activities of daily living, withdrawal-emergent hyperpyrexia (a syndrome resembling neuroleptic malignant syndrome) </p>
<p><b>Postmarketing reports</b>: Coma, delirium, hypokinesia, involuntary muscle contractions, gait abnormalities, paresthesia, EEG changes, tremor<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Very common</b> (10% or more): Hallucinations (up to 21%) </p>
<p><b>Common</b> (1% to 10%): Insomnia, depression, anxiety, irritability, hallucinations, confusion, nervousness, abnormal dreams, agitation</p>
<p><b>Uncommon</b> (0.1% to 1%): Psychosis, euphoria, abnormal thinking, amnesia</p>
<p><b>Rare</b> (less than 0.1%): Suicide attempt, suicide, suicidal ideation</p>
<p><b>Postmarketing reports</b>: Stupor, delusions, aggressive behavior, paranoid reaction, manic reaction, pathological gambling, increased libido including hypersexuality, and impulse control symptoms<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Dry mouth (up to 16%); constipation (up to 13%)</p>
<p><b>Common</b> (1% to 10%): Nausea, anorexia, diarrhea, decreased appetite</p>
<p><b>Uncommon</b> (0.1% to 1%): Vomiting</p>
<p><b>Postmarketing reports</b>: Dysphagia<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): Peripheral edema (up to 16%), orthostatic hypotension (up to 13%) </p>
<p><b>Uncommon</b> (0.1% to 1%): Congestive heart failure, hypertension </p>
<p><b>Postmarketing reports</b>: Cardiac arrest, arrhythmias including malignant arrhythmias, hypotension, and tachycardia<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Common</b> (1% to 10%): Dry eye, cataract, blurred vision</p>
<p><b>Uncommon</b> (0.1% to 1%): Visual disturbance, punctate subeithelial or other corneal opacity, corneal edema, decreased visual acuity, sensitivity to light, optic nerve palsy</p>
<p><b>Rare</b> (less than 0.1%): Oculogyric episodes </p>
<p><b>Postmarketing reports</b>: Keratitis, mydriasis<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Fall (up to 13%) </p>
<p><b>Common</b> (1% to 10%): Fatigue, contusions</p>
<p><b>Frequency not reported</b>: Death</p>
<p><b>Postmarketing reports</b>: Fever<sup>[Ref]</sup></p><p>Deaths have been reported from overdose with the lowest reported acute lethal dose as 1 gram.  Drug overdose has resulted in cardiac, respiratory, renal, or CNS toxicity.  Deaths have been reported in patients with renal impairment and attributed to drug accumulation.<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Dry nose, cough</p>
<p><b>Uncommon</b> (0.1% to 1%): Dyspnea</p>
<p><b>Postmarketing reports</b>: Acute respiratory failure, pulmonary edema, tachypnea<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Rare</b> (less than 0.1%): Leukopenia, neutropenia</p>
<p><b>Postmarketing reports</b>: Leukocytosis, agranulocytosis<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Livedo reticularis, pigmentation disorder</p>
<p><b>Uncommon</b> (0.1% to 1%): Skin rash</p>
<p><b>Rare</b> (less than 0.1%): Eczematoid dermatitis </p>
<p><b>Postmarketing reports</b>: Pruritus, diaphoresis<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Postmarketing reports</b>: Allergic reactions including anaphylactic reactions<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Urinary tract infection, benign prostatic hyperplasia</p>
<p><b>Uncommon</b> (0.1% to 1%): Urinary retention, decreased libido<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Postmarketing reports</b>: Elevated: CPK, BUN, serum creatinine<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Rare</b> (less than 0.1%): Reversible liver enzyme elevations</p>
<p><b>Postmarketing reports</b>: Elevated: alkaline phosphatase, LDH, bilirubin, GGT, SGOT, and SGPT<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Joint swelling, muscle spasms<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Gocovri (amantadine)." Adamas Pharmaceuticals Inc., Emeryville, CA. </p><p id="ref_2">2. "Product Information. Amantadine Hydrochloride (amantadine)." Sandoz Inc, Broomfield, CO. </p><p id="ref_3">3. "Product Information. Symmetrel (amantadine)." DuPont Pharmaceuticals, Wilmington, DE. </p><p id="ref_4">4. Smith EJ "Amantadine-induced psychosis in a young healthy patient." Am J Psychiatry 165 (2008): 1613</p><p id="ref_5">5. Michalski LS,  Hantsch Bardsley C,  Holt DR,  Milner JE,  Hou SH "Altered mental status in a transplant patient. Amantadine toxicity." Kidney Int 75 (2009): 243-4</p><p id="ref_6">6. Kataoka H,  Ueno S "Dropped head associated with amantadine in Parkinson disease." Clin Neuropharmacol 34 (2011): 48-9</p><p id="ref_7">7. "Antiviral drugs for influenza." Med Lett Drugs Ther 51 (2009): 89-92</p><p id="ref_8">8. Beal E "Parkinson disease: Amantadine administration is associated with impulse control disorders in PD." Nat Rev Neurol 7 (2011): 62</p><p id="ref_9">9. Salgado JC,  Gutknecht DR "A reticular rash." Am J Med 119 (2006): 577-8</p><p id="ref_10">10. Alonso Navarro H,  Sanz-Aiz A,  Izquierdo L,  Jimenez Jimenez FJ "Syndrome of Inappropriate Antidiuretic Hormone Secretion Possibly Associated With Amantadine Therapy in Parkinson Disease." Clin Neuropharmacol 32 (2009): 167-168</p></div>
<h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2>
<ul>
<li>How long does it take for amantadine to start working?</li>
<li>Why should you not discontinue amantadine?</li>
<li>What symptoms does amantadine treat?</li>
<li>What is Gocovri (amantadine) and how does it work?</li>
<li>What is the difference between Osmolex ER and Gocovri?</li>
<li>What is Gocovri used to treat?</li>
</ul>
<div class="more-resources" id="moreResources">
<h2>More about Gocovri (amantadine)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Imprints, Shape &amp; Color Data</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>Drug class: dopaminergic antiparkinsonism agents</li>
<li>FDA Alerts (2)</li>
<li>FDA Approval History</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Gocovri &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Symmetrel, Osmolex ER</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Parkinson's Disease</li>
<li>Extrapyramidal Reaction</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to amantadine: compounding powder, oral capsule, oral capsule extended release, oral syrup, oral tablet, oral tablet extended release</i></p><h3>General</h3><p>The more commonly reported adverse reactions have included nausea, dizziness/lightheadedness, and insomnia.<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Dizziness/lightheadedness, ataxia, headache, somnolence, dystonia</p><p><b>Uncommon</b> (0.1% to 1%): Weakness, slurred speech, hyperkinesia </p><p><b>Rare</b> (less than 0.1%): Convulsion</p><p><b>Frequency not reported</b>: Falling asleep during activities of daily living, withdrawal-emergent hyperpyrexia (a syndrome resembling neuroleptic malignant syndrome) </p><p><b>Postmarketing reports</b>: Coma, delirium, hypokinesia, involuntary muscle contractions, gait abnormalities, paresthesia, EEG changes, tremor<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Very common</b> (10% or more): Hallucinations (up to 21%) </p><p><b>Common</b> (1% to 10%): Insomnia, depression, anxiety, irritability, hallucinations, confusion, nervousness, abnormal dreams, agitation</p><p><b>Uncommon</b> (0.1% to 1%): Psychosis, euphoria, abnormal thinking, amnesia</p><p><b>Rare</b> (less than 0.1%): Suicide attempt, suicide, suicidal ideation</p><p><b>Postmarketing reports</b>: Stupor, delusions, aggressive behavior, paranoid reaction, manic reaction, pathological gambling, increased libido including hypersexuality, and impulse control symptoms<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Dry mouth (up to 16%); constipation (up to 13%)</p><p><b>Common</b> (1% to 10%): Nausea, anorexia, diarrhea, decreased appetite</p><p><b>Uncommon</b> (0.1% to 1%): Vomiting</p><p><b>Postmarketing reports</b>: Dysphagia<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): Peripheral edema (up to 16%), orthostatic hypotension (up to 13%) </p><p><b>Uncommon</b> (0.1% to 1%): Congestive heart failure, hypertension </p><p><b>Postmarketing reports</b>: Cardiac arrest, arrhythmias including malignant arrhythmias, hypotension, and tachycardia<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Common</b> (1% to 10%): Dry eye, cataract, blurred vision</p><p><b>Uncommon</b> (0.1% to 1%): Visual disturbance, punctate subeithelial or other corneal opacity, corneal edema, decreased visual acuity, sensitivity to light, optic nerve palsy</p><p><b>Rare</b> (less than 0.1%): Oculogyric episodes </p><p><b>Postmarketing reports</b>: Keratitis, mydriasis<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Fall (up to 13%) </p><p><b>Common</b> (1% to 10%): Fatigue, contusions</p><p><b>Frequency not reported</b>: Death</p><p><b>Postmarketing reports</b>: Fever<sup>[Ref]</sup></p><p>Deaths have been reported from overdose with the lowest reported acute lethal dose as 1 gram.  Drug overdose has resulted in cardiac, respiratory, renal, or CNS toxicity.  Deaths have been reported in patients with renal impairment and attributed to drug accumulation.<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Dry nose, cough</p><p><b>Uncommon</b> (0.1% to 1%): Dyspnea</p><p><b>Postmarketing reports</b>: Acute respiratory failure, pulmonary edema, tachypnea<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Rare</b> (less than 0.1%): Leukopenia, neutropenia</p><p><b>Postmarketing reports</b>: Leukocytosis, agranulocytosis<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Livedo reticularis, pigmentation disorder</p><p><b>Uncommon</b> (0.1% to 1%): Skin rash</p><p><b>Rare</b> (less than 0.1%): Eczematoid dermatitis </p><p><b>Postmarketing reports</b>: Pruritus, diaphoresis<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Postmarketing reports</b>: Allergic reactions including anaphylactic reactions<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Urinary tract infection, benign prostatic hyperplasia</p><p><b>Uncommon</b> (0.1% to 1%): Urinary retention, decreased libido<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Postmarketing reports</b>: Elevated: CPK, BUN, serum creatinine<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Rare</b> (less than 0.1%): Reversible liver enzyme elevations</p><p><b>Postmarketing reports</b>: Elevated: alkaline phosphatase, LDH, bilirubin, GGT, SGOT, and SGPT<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Joint swelling, muscle spasms<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Gocovri (amantadine)." Adamas Pharmaceuticals Inc., Emeryville, CA. </p><p id="ref_2">2. "Product Information. Amantadine Hydrochloride (amantadine)." Sandoz Inc, Broomfield, CO. </p><p id="ref_3">3. "Product Information. Symmetrel (amantadine)." DuPont Pharmaceuticals, Wilmington, DE. </p><p id="ref_4">4. Smith EJ "Amantadine-induced psychosis in a young healthy patient." Am J Psychiatry 165 (2008): 1613</p><p id="ref_5">5. Michalski LS,  Hantsch Bardsley C,  Holt DR,  Milner JE,  Hou SH "Altered mental status in a transplant patient. Amantadine toxicity." Kidney Int 75 (2009): 243-4</p><p id="ref_6">6. Kataoka H,  Ueno S "Dropped head associated with amantadine in Parkinson disease." Clin Neuropharmacol 34 (2011): 48-9</p><p id="ref_7">7. "Antiviral drugs for influenza." Med Lett Drugs Ther 51 (2009): 89-92</p><p id="ref_8">8. Beal E "Parkinson disease: Amantadine administration is associated with impulse control disorders in PD." Nat Rev Neurol 7 (2011): 62</p><p id="ref_9">9. Salgado JC,  Gutknecht DR "A reticular rash." Am J Med 119 (2006): 577-8</p><p id="ref_10">10. Alonso Navarro H,  Sanz-Aiz A,  Izquierdo L,  Jimenez Jimenez FJ "Syndrome of Inappropriate Antidiuretic Hormone Secretion Possibly Associated With Amantadine Therapy in Parkinson Disease." Clin Neuropharmacol 32 (2009): 167-168</p><h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2><ul>
<li>How long does it take for amantadine to start working?</li>
<li>Why should you not discontinue amantadine?</li>
<li>What symptoms does amantadine treat?</li>
<li>What is Gocovri (amantadine) and how does it work?</li>
<li>What is the difference between Osmolex ER and Gocovri?</li>
<li>What is Gocovri used to treat?</li>
</ul><h2>More about Gocovri (amantadine)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Imprints, Shape &amp; Color Data</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>Drug class: dopaminergic antiparkinsonism agents</li>
<li>FDA Alerts (2)</li>
<li>FDA Approval History</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Gocovri &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Parkinson's Disease</li>
<li>Extrapyramidal Reaction</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>